Cytotoxic activities of some benzothiazole-piperazine derivatives
dc.citation.epage | 654 | en_US |
dc.citation.issueNumber | 4 | en_US |
dc.citation.spage | 649 | en_US |
dc.citation.volumeNumber | 30 | en_US |
dc.contributor.author | Gurdal, E.E. | en_US |
dc.contributor.author | Durmaz I. | en_US |
dc.contributor.author | Cetin-Atalay, R. | en_US |
dc.contributor.author | Yarim, M. | en_US |
dc.date.accessioned | 2016-02-08T09:45:30Z | |
dc.date.available | 2016-02-08T09:45:30Z | |
dc.date.issued | 2015 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | Synthesis, characterization and cytotoxic activities of ten benzothiazole-piperazine derivatives were reported. In vitro cytotoxic activities of compounds were screened against hepatocellular (HUH-7), breast (MCF-7) and colorectal (HCT-116) cancer cell lines by sulphorhodamine B assay. Based on the GI<inf>50</inf> values of the compounds, most of the benzothiazole-piperazine derivatives are active against HUH-7, MCF-7 and HCT-116 cancer cell lines. Compound 1d is highly cytotoxic against all tested cancer cell lines. Further investigation of compound 1d by Hoechst Staining and Fluorescence-Activated Cell Sorting Analysis (FACS) revealed that this compound causes apoptosis by cell cycle arrest at subG<inf>1</inf> phase. © 2014 Informa UK Ltd. All rights reserved. | en_US |
dc.description.provenance | Made available in DSpace on 2016-02-08T09:45:30Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2015 | en |
dc.identifier.doi | 10.3109/14756366.2014.959513 | en_US |
dc.identifier.issn | 14756366 | |
dc.identifier.uri | http://hdl.handle.net/11693/21381 | |
dc.language.iso | English | en_US |
dc.publisher | Taylor and Francis Ltd | en_US |
dc.relation.isversionof | http://dx.doi.org/10.3109/14756366.2014.959513 | en_US |
dc.source.title | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.subject | Anticancer | en_US |
dc.subject | benzothiazole | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | piperazine | en_US |
dc.subject | sulphorodamine B | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | benzothiazole derivative | en_US |
dc.subject | fluorouracil | en_US |
dc.subject | n (6 ethoxybenzothiazol 2 yl) 2 [4 (o chlorophenyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 ethoxybenzothiazol 2 yl) 2 [4 (o cyanophenyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 ethoxybenzothiazol 2 yl) 2 [4 (p cyanophenyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 ethoxybenzothiazol 2 yl) 2 [4 (p toluyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 (4 cyclohexylpiperazinyl)acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 [4 (2 methoxyethyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 [4 (2 methoxyphenyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 [4 (3,4 dichlorophenyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 [4 (4 chlorobenzyl)piperazinyl]acetamide | en_US |
dc.subject | n (6 methylbenzothiazol 2 yl) 2 [4 (pyridin 4 yl)piperazinyl]acetamide | en_US |
dc.subject | piperazine derivative | en_US |
dc.subject | sulforhodamine B | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | apoptosis | en_US |
dc.subject | Article | en_US |
dc.subject | cancer cell line | en_US |
dc.subject | cell cycle arrest | en_US |
dc.subject | cell cycle G1 phase | en_US |
dc.subject | chemical structure | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug cytotoxicity | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | fluorescence activated cell sorting | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | human cell culture | en_US |
dc.subject | in vitro study | en_US |
dc.subject | priority journal | en_US |
dc.subject | proton nuclear magnetic resonance | en_US |
dc.title | Cytotoxic activities of some benzothiazole-piperazine derivatives | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cytotoxic activities of some benzothiazole-piperazine derivatives.pdf
- Size:
- 869.97 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version